Alexandra Calmy
Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland
Gueler A, Egger M, Wandeler G, Ledergerber B, Cavassini M, Calmy A, Bucher H, Bertisch B, Moser A, Schoeni-Affolter F, Swiss HIV Cohort Study, Swiss National Cohort. Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland. AIDS 2015; 29:231-8.
Jan 14, 2015Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland
Jan 14, 2015AIDS 2015; 29:231-8
Gueler Aysel, Egger Matthias, Wandeler Gilles, Ledergerber Bruno, Cavassini Matthias, Calmy Alexandra, Bucher Heiner C, Bertisch Barbara, Moser André, Schoeni-Affolter Franziska, Swiss HIV Cohort Study, Swiss National Cohort
Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Metzner K, Günthard H, Weber R, Bernasconi E, Calmy A, Cavassini M, Vernazza P, Hirsch H, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, von Wyl V, Scherrer A, the Swiss HIV Cohort Study. Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients. AIDS 2014; 28:2231-2239.
Sep 24, 2014Limited clinical benefit of minority K103N and Y181C-variant detection in addition to routine genotypic resistance testing in antiretroviral therapy-naive patients
Sep 24, 2014AIDS 2014; 28:2231-2239
Metzner Karin J, Günthard Huldrych F, Weber Rainer, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Vernazza Pietro, Hirsch Hans H, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Scherrer Alexandra U, the Swiss HIV Cohort Study
Disentangling human tolerance and resistance against HIV
Regoes R, Fellay J, Telenti A, Rauch A, Hoffmann M, Günthard H, Calmy A, Bernasconi E, Battegay M, McLaren P. Disentangling human tolerance and resistance against HIV. PLoS Biol 2014; 12:e1001951.
Sep 16, 2014Disentangling human tolerance and resistance against HIV
Sep 16, 2014PLoS Biol 2014; 12:e1001951
Regoes Roland R, Fellay Jacques, Telenti Amalio, Rauch Andri, Hoffmann Matthias, Günthard Huldrych F, Calmy Alexandra, Bernasconi Enos, Battegay Manuel, McLaren Paul J
Clinical significance of the CCR5delta32 allele in hepatitis C
Morard I, Negro F, Bochud P, Pascarella S, Semela D, Mullhaupt B, Moradpour D, Malinverni R, Heim M, Gorgievski M, De Gottardi A, Cerny A, Mangia A, Calmy A, Clément S, Swiss Hepatitis C Cohort Study Group. Clinical significance of the CCR5delta32 allele in hepatitis C. PloS one 2014; 9:e106424.
Sep 5, 2014Clinical significance of the CCR5delta32 allele in hepatitis C
Sep 5, 2014PloS one 2014; 9:e106424
Morard Isabelle, Negro Franco, Bochud Pierre-Yves, Pascarella Stéphanie, Semela David, Mullhaupt Beat, Moradpour Darius, Malinverni Raffaele, Heim Markus, Gorgievski Meri, De Gottardi Andrea, Cerny Andrea, Mangia Alessandra, Calmy Alexandra, Clément Sophie, Swiss Hepatitis C Cohort Study Group
[Antiretroviral therapy]
von Braun A, Furrer H, Battegay M, Calmy A, Cavassini M, Vernazza P, Bernasconi E, Weber R, Günthard H. [Antiretroviral therapy]. Ther Umsch 2014; 71:461-8.
Aug 1, 2014[Antiretroviral therapy]
Aug 1, 2014Ther Umsch 2014; 71:461-8
von Braun Amrei, Furrer Hansjakob, Battegay Manuel, Calmy Alexandra, Cavassini Matthias, Vernazza Pietro, Bernasconi Enos, Weber Rainer, Günthard Huldrych F
Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide
Kouyos R, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Cavassini M, Calmy A, Kovari H, Shah C, Aubert V, Klimkait T, Yerly S, Böni J, Yang W, Braun D, Rauch A, Günthard H. Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide. J Infect Dis 2014; 210:1555-61.
Jun 18, 2014Higher Risk of Incident Hepatitis C Virus Coinfection Among Men Who Have Sex With Men, in Whom the HIV Genetic Bottleneck at Transmission Was Wide
Jun 18, 2014J Infect Dis 2014; 210:1555-61
Kouyos Roger D, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Cavassini Matthias, Calmy Alexandra, Kovari Helen, Shah Cyril, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, Yang Wan-Lin, Braun Dominique L, Rauch Andri, Günthard Huldrych F
Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
Wang Q, Battegay M, Bucher H, Fehr J, Furrer H, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Young J, Swiss HIV Cohort Study. Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone. HIV Clin Trials 2014; 15:92-103.
May 1, 2014Virologic and immunologic responses in treatment-naive patients to ritonavir-boosted atazanavir or efavirenz with a common backbone
May 1, 2014HIV Clin Trials 2014; 15:92-103
Wang Qing, Battegay Manuel, Bucher Heiner C, Fehr Jan, Furrer Hansjakob, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Bernasconi Enos, Young Jim, Swiss HIV Cohort Study
Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study
Hasse B, Ledergerber B, Weber R, Di Benedetto C, Fellay J, Calmy A, Battegay M, Hoffmann M, Furrer H, Fehr J, Walker A, Swiss HIV Cohort Study. Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study. Antimicrob Agents Chemother 2014; 58:2363-8.
Feb 10, 2014Co-trimoxazole prophylaxis is associated with reduced risk of incident tuberculosis in participants in the Swiss HIV Cohort Study
Feb 10, 2014Antimicrob Agents Chemother 2014; 58:2363-8
Hasse Barbara, Ledergerber Bruno, Weber Rainer, Di Benedetto Caroline, Fellay Jacques, Calmy Alexandra, Battegay Manuel, Hoffmann Matthias, Furrer Hansjakob, Fehr Jan, Walker A Sarah, Swiss HIV Cohort Study
Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV
Kouyos R, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Cavassini M, Calmy A, Kovari H, Klimkait T, Aubert V, Shah C, Yerly S, Böni J, Rauch A, Swiss HIV Cohort Study (SHCS). Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV. Int J Epidemiol 2014; 43:887-96.
Jan 22, 2014Clustering of HCV coinfections on HIV phylogeny indicates domestic and sexual transmission of HCV
Jan 22, 2014Int J Epidemiol 2014; 43:887-96
Kouyos Roger D, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Cavassini Matthias, Calmy Alexandra, Kovari Helen, Klimkait Thomas, Aubert Vincent, Shah Cyril, Yerly Sabine, Böni Jürg, Rauch Andri, Swiss HIV Cohort Study (SHCS)
Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study
Conen A, Battegay M, Bucher H, Weber R, Vernazza P, Bernasconi E, Calmy A, Orasch C, Thurnheer M, Fux C, Glass T, Wang Q, Fehr J. Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study. J Acquir Immune Defic Syndr 2013; 64:472-8.
Dec 15, 2013Association of alcohol consumption and HIV surrogate markers in participants of the swiss HIV cohort study
Dec 15, 2013J Acquir Immune Defic Syndr 2013; 64:472-8
Conen Anna, Battegay Manuel, Bucher Heiner C, Weber Rainer, Vernazza Pietro, Bernasconi Enos, Calmy Alexandra, Orasch Christina, Thurnheer Maria C, Fux Christoph A, Glass Tracy R, Wang Qing, Fehr Jan
Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study
von Wyl V, Glass T, Bucher H, Günthard H, Aubert V, Böni J, Bernasconi E, Calmy A, Cavassini M, Furrer H, Nicca D, Yerly S, Klimkait T, Swiss HIV Cohort Study. Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study. PloS one 2013; 8:e77691.
Oct 16, 2013Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study
Oct 16, 2013PloS one 2013; 8:e77691
von Wyl Viktor, Glass Tracy R, Bucher Heiner C, Günthard Huldrych F, Aubert Vincent, Böni Jürg, Bernasconi Enos, Calmy Alexandra, Cavassini Matthias, Furrer Hansjakob, Nicca Dunja, Yerly Sabine, Klimkait Thomas, Swiss HIV Cohort Study
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study
Bertisch B, Clifford G, Stöckle M, Cavassini M, Calmy A, Wandeler G, Kovari H, Pawlita M, ess s, Jundt G, Levi F, Dehler S, Bouchardy C, Schöni-Affolter F, Keiser O, Vernazza P, Lise M, Franceschi S, Swiss HIV Cohort Study Investigators. Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study. Am J Epidemiol 2013; 178:877-84.
Jul 30, 2013Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study
Jul 30, 2013Am J Epidemiol 2013; 178:877-84
Bertisch Barbara, Clifford Gary, Stöckle Marcel, Cavassini Matthias, Calmy Alexandra, Wandeler Gilles, Kovari Helen, Pawlita Michael, ess silvia, Jundt Gernot, Levi Fabio, Dehler Silvia, Bouchardy Christine, Schöni-Affolter Franziska, Keiser Olivia, Vernazza Pietro, Lise Mauro, Franceschi Silvia, Swiss HIV Cohort Study Investigators
Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study
Wandeler G, Rauch A, Furrer H, Egger M, Calmy A, Battegay M, Schmid P, Kovari H, Cavassini M, Bernasconi E, Bihl F, Gsponer T, Swiss HIV Cohort Study. Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study. J Infect Dis 2013; 208:1454-8.
Jul 30, 2013Hepatitis B virus infection is associated with impaired immunological recovery during antiretroviral therapy in the Swiss HIV cohort study
Jul 30, 2013J Infect Dis 2013; 208:1454-8
Wandeler Gilles, Rauch Andri, Furrer Hansjakob, Egger Matthias, Calmy Alexandra, Battegay Manuel, Schmid Patrick, Kovari Helen, Cavassini Matthias, Bernasconi Enos, Bihl Florian, Gsponer Thomas, Swiss HIV Cohort Study
Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, the Swiss HIV Cohort Study (SHCS). Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens. PloS one 2013; 8
Jul 25, 2013Correction: Long-Lasting Protection of Activity of Nucleoside Reverse Transcriptase Inhibitors and Protease Inhibitors (PIs) by Boosted PI Containing Regimens
Jul 25, 2013PloS one 2013; 8
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, the Swiss HIV Cohort Study (SHCS)
Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Metzner K, Aubert V, Furrer H, Battegay M, Vernazza P, Cavassini M, Calmy A, Bernasconi E, Weber R, Günthard H, Klimkait T, Yerly S, Böni J, Scherrer A, Preiswerk B, Joos B, von Wyl V, Leemann C, Rieder P, Braun D, Grube C, Kuster H, Swiss HIV Cohort Study. Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection. J Infect Dis 2013; 208:1102-12.
Jul 11, 2013Origin of minority drug-resistant HIV-1 variants in primary HIV-1 infection
Jul 11, 2013J Infect Dis 2013; 208:1102-12
Metzner Karin J, Aubert Vincent, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Cavassini Matthias, Calmy Alexandra, Bernasconi Enos, Weber Rainer, Günthard Huldrych F, Klimkait Thomas, Yerly Sabine, Böni Jürg, Scherrer Alexandra U, Preiswerk Benjamin, Joos Beda, von Wyl Viktor, Leemann Christine, Rieder Philip, Braun Dominique, Grube Christina, Kuster Herbert, Swiss HIV Cohort Study
Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)
Nüesch R, Bucher H, Battegay M, Calmy A, Thurnheer M, Vernazza P, Cavassini M, Weber R, Bernasconi E, Elzi L, Wang Q, Swiss HIV Cohort Study. Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS). J Acquir Immune Defic Syndr 2013; 62:396-404.
Apr 1, 2013Risk of cardiovascular events and blood pressure control in hypertensive HIV-infected patients: Swiss HIV Cohort Study (SHCS)
Apr 1, 2013J Acquir Immune Defic Syndr 2013; 62:396-404
Nüesch Reto, Bucher Heiner C, Battegay Manuel, Calmy Alexandra, Thurnheer Maria C, Vernazza Pietro, Cavassini Matthias, Weber Rainer, Bernasconi Enos, Elzi Luigia, Wang Qing, Swiss HIV Cohort Study
HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis
Fenner L, Cavassini M, Calmy A, Dolina M, Frei R, Janssens J, Borrell S, Stucki D, Schrenzel J, Böttger E, Gagneux S, Bernasconi E, Hoffmann M, Egger M, Bodmer T, Furrer H, Ballif M, Battegay M, Helbling P, Fehr J, Gsponer T, Rieder H, Zwahlen M, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups. HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis. PLoS Genet 2013; 9:e1003318.
Mar 7, 2013HIV Infection Disrupts the Sympatric Host-Pathogen Relationship in Human Tuberculosis
Mar 7, 2013PLoS Genet 2013; 9:e1003318
Fenner Lukas, Cavassini Matthias, Calmy Alexandra, Dolina Marisa, Frei Reno, Janssens Jean-Paul, Borrell Sonia, Stucki David, Schrenzel Jacques, Böttger Erik C, Gagneux Sebastien, Bernasconi Enos, Hoffmann Matthias, Egger Matthias, Bodmer Thomas, Furrer Hansjakob, Ballif Marie, Battegay Manuel, Helbling Peter, Fehr Jan, Gsponer Thomas, Rieder Hans L, Zwahlen Marcel, Swiss HIV Cohort and Molecular Epidemiology of Tuberculosis Study Groups
HIV-infected women in Europe: gender-specific needs and challenges
Bertisch B, Grinsztejn B, Calmy A. HIV-infected women in Europe: gender-specific needs and challenges. Antivir Ther (Lond) 2013; 18:549-51.
Jan 1, 2013HIV-infected women in Europe: gender-specific needs and challenges
Jan 1, 2013Antivir Ther (Lond) 2013; 18:549-51
Bertisch Barbara, Grinsztejn Beatriz, Calmy Alexandra
Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
Scherrer A, Günthard H, Ledergerber B, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Calmy A, Furrer H, Aubert V, Klimkait T, Yerly S, Böni J, Swiss HIV Cohort Study (SHCS). Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens. PloS one 2012; 7:e50307.
Nov 26, 2012Long-lasting protection of activity of nucleoside reverse transcriptase inhibitors and protease inhibitors (PIs) by boosted PI containing regimens
Nov 26, 2012PloS one 2012; 7:e50307
Scherrer Alexandra U, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Calmy Alexandra, Furrer Hansjakob, Aubert Vincent, Klimkait Thomas, Yerly Sabine, Böni Jürg, Swiss HIV Cohort Study (SHCS)
Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic
Wandeler G, Rauch A, Furrer H, Bernasconi E, Stöckle M, Calmy A, Clerc O, Günthard H, Bregenzer A, Gsponer T, Swiss HIV Cohort Study. Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic. Clin Infect Dis 2012; 55:1408-16.
Aug 14, 2012Hepatitis C virus infections in the Swiss HIV Cohort Study: a rapidly evolving epidemic
Aug 14, 2012Clin Infect Dis 2012; 55:1408-16
Wandeler Gilles, Rauch Andri, Furrer Hansjakob, Bernasconi Enos, Stöckle Marcel, Calmy Alexandra, Clerc Olivier, Günthard Huldrych F, Bregenzer Andrea, Gsponer Thomas, Swiss HIV Cohort Study